By reporting morphological evidence of high level of SPARC, MMP and MMP9 in these patients, our results may yield important sight into pathogenesis of intracranial aneurysms and open avenues for the investigation of new therapeutics in this disease. The gene discussed is MMP9; the disease is Dilatation of the cerebral artery.